INS and Hypoglycemia: Of the two groups between glyburide and insulin, glyburide had a higher risk of neonatal hypoglycemia compared with insulin (RR, 1.76; 95% CI, 1.32 to 2.36; P < 0.001), which is the same as the study [23].